A multispectral 3D live organoid imaging platform to screen probes for fluorescence guided surgery
Open Access
- 3 June 2024
- journal article
- research article
- Published by Springer Nature in EMBO Molecular Medicine
- Vol. 16 (7) , 1495-1514
Abstract
Achieving complete tumor resection is challenging and can be improved by real-time fluorescence-guided surgery with molecular-targeted probes. However, pre-clinical identification and validation of probes presents a lengthy process that is traditionally performed in animal models and further hampered by inter- and intra-tumoral heterogeneity in target expression. To screen multiple probes at patient scale, we developed a multispectral real-time 3D imaging platform that implements organoid technology to effectively model patient tumor heterogeneity and, importantly, healthy human tissue binding.Keywords
Funding Information
- Stichting Villa Joep
- HORIZON EUROPE European Research Council (804412)
- Prinses Máxima Centrum voor kinderoncologie
- Oncode Institute
This publication has 47 references indexed in Scilit:
- Comprehensive Genomic Analysis Identifies Novel Subtypes and Targets of Triple-Negative Breast CancerClinical Cancer Research, 2015
- Proper genomic profiling of (BRCA1‐mutated) basal‐like breast carcinomas requires prior removal of tumor infiltrating lymphocytesMolecular Oncology, 2015
- L1CAM is expressed in triple-negative breast cancers and is inversely correlated with Androgen receptorBMC Cancer, 2014
- Research-Based PAM50 Subtype Predictor Identifies Higher Responses and Improved Survival Outcomes in HER2-Positive Breast Cancer in the NOAH StudyClinical Cancer Research, 2014
- Cerebral organoids model human brain development and microcephalyNature, 2013
- Anti-GD2 Antibody with GM-CSF, Interleukin-2, and Isotretinoin for NeuroblastomaNew England Journal of Medicine, 2010
- A robust method for estimating gene expression states using Affymetrix microarray probe level dataBMC Bioinformatics, 2010
- G-protein-coupled receptors in aldosterone-producing adenomas: a potential cause of hyperaldosteronismJournal of Endocrinology, 2007
- Identification of candidate genes involved in neuroblastoma progression by combining genomic and expression microarrays with survival dataOncogene, 2007
- Characterization of Human Neuroblastoma Cell Lines Established Before and After Therapy23JNCI: Journal of the National Cancer Institute, 1986